Bali Chronic Constipation Roundtable Report: Chronic ConstipationManagement in Asia
- Author:
Yi Ping REN
1
;
Wah Loong CHAN
;
Kee Huat CHUAH
;
Yong Sung KIM
;
Atsushi NAKAJIMA
;
Sanjiv MAHADEVA
;
Yeong Yeh LEE
;
Andrew S B CHUA
;
Tao BAI
;
Ari Fahrial SYAM
;
Chien-Lin CHEN
;
Ching-Liang LU
;
M. Masudur RAHMAN
;
Tanisa PATCHARATRAKUL
;
Victoria Ping Y TAN
;
Dao Viet HANG
;
Xiaohua HOU
;
Yinglian XIAO
;
Justin WU
;
Uday C GHOSHAL
;
Hidekazu SUZUKI
;
Sutep GONLACHANVIT
;
Kewin T H SIAH
Author Information
- Publication Type:Original Article
- From:Journal of Neurogastroenterology and Motility 2026;32(1):109-128
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background/Aims:Chronic constipation is prevalent yet under-diagnosed across Asia, compromising quality of life and burdening healthcare systems. Cultural stigma, varied diets, and limited access to standardized diagnostic tools delay timely care.
Methods:The Bali Chronic Constipation Roundtable in November 2024, brought together experts from 11 Asian countries. The group reviewed epidemiological data, analyzed multinational questionnaire on clinical practice pattern, and conducted structured discussions to identify key barriers and propose region-specific recommendations.
Results:Chronic constipation prevalence varies across Asia, ranging from 1.8% in India to 16.6% in Japan, with women and the elderly disproportionately affected. Under-reporting persists owing to cultural taboos and widespread self treatment with laxatives and traditional medications. Although the Rome IV criteria remains the global standard, they may not fully reflect Asian symptom profiles, and diagnosis is limited by scarce motility laboratories. First line therapies such as dietary-fiber optimization and osmotic laxatives are widely available, but newer pharmacotherapies (prucalopride, linaclotide, lubiprostone, and elobixibat) remain costly and unevenly accessible. Biofeedback for dyssynergic defecation is underutilized due to limited availability. Experts recommend expanded regional research on to refine diagnostic criteria, coupled with enhanced physician education and public awareness. They advocate accessibility to second-line and novel therapies that incorporate culturally attuned regional guidelines, and improved access to gastrointestinal motility testing.
Conclusions:The Bali Chronic Constipation Roundtable highlighted Asia’s need for region specific diagnostics and management. Addressing diagnostic and treatment gaps will improve outcomes, while ongoing researcher clinician policy collaboration must standardize guidelines, advance research, and ensure equitable care across Asia.
